3-(((5-Bromofuran-2-yl)methyl)amino)tetrahydrothiophene 1,1-dioxide hydrochloride

Catalog No.: 
ACMFWL482
CAS No.: 
1774896-58-0
Molecular Formula: 
C9H13BrClNO3S
Molecular Weight: 
330.63
3-(((5-Bromofuran-2-yl)methyl)amino)tetrahydrothiophene 1,1-dioxide hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-(((5-Bromofuran-2-yl)methyl)amino)tetrahydrothiophene 1,1-dioxide hydrochloride
IUPAC Name3-(((5-bromofuran-2-yl)methyl)amino)tetrahydrothiophene 1,1-dioxide hydrochloride
Molecular FormulaC9H13BrClNO3S
Molecular Weight330.63
SMILESBrC1=CC=C(CNC(CC2)CS2(=O)=O)O1.[H]Cl
InChI KeyGUEWMWWWWXGPMI-UHFFFAOYSA-N
Synonym2-Furanmethanamine, 5-bromo-N-(tetrahydro-1,1-dioxido-3-thienyl)-, hydrochloride (1:1)
CAS No.1774896-58-0

Synthetic Route by SureRoute

1. ACMFWL482 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACYWFA378 route compound structure diagram
    ACYWFA37851642-03-6In Stock
  2. Plus
  3. ACRUXI465 route compound structure diagram
    ACRUXI4651899-24-7In Stock
  4. Then
  5. ACMFWL482 route product structure diagram
    ACMFWL4821774896-58-0
Inquiry

2. ACMFWL482 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACYWFA378 route compound structure diagram
    ACYWFA37851642-03-6In Stock
  4. Then
  5. ACMFWL482 route product structure diagram
    ACMFWL4821774896-58-0
Inquiry

3. ACMFWL482 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTKSM985 route compound structure diagram
    ACTKSM9851803600-05-6In Stock
  2. Plus
  3. ACQWAT564 route compound structure diagram
    ACQWAT56417115-51-4In Stock
  4. Then
  5. ACMFWL482 route product structure diagram
    ACMFWL4821774896-58-0
Inquiry

Comments (0)